EFFECT OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS ON BIOMARKERS OF CARDIAC REMODELING: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引:0
作者
Ros, Marta Lorente
Ros, Alvaro Lorente
Romeo, Francisco Jose
Gallardo, Jose Aguilar
Mahmood, Kiran
机构
[1] Georgetown Univ, Medstar Washington Hosp Ctr, Washington, DC USA
[2] Icahn Sch Med Mt Sinai, New York, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1343-123
引用
收藏
页码:553 / 553
页数:1
相关论文
共 50 条
  • [31] Effect of sodium-glucose cotransporter-2 inhibitors on cardiac remodelling: a systematic review and meta-analysis
    Zhang, Nan
    Wang, Yueying
    Tse, Gary
    Korantzopoulos, Panagiotis
    Letsas, Konstantinos P.
    Zhang, Qingpeng
    Li, Guangping
    Lip, Gregory Y. H.
    Liu, Tong
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 28 (17) : 1961 - 1973
  • [32] The effect of sodium-glucose co-transporter-2 inhibitors on markers of subclinical atherosclerosis
    Stachteas, Panagiotis
    Karakasis, Paschalis
    Patoulias, Dimitrios
    Clemenza, Francesco
    Fragakis, Nikolaos
    Rizzo, Manfredi
    [J]. ANNALS OF MEDICINE, 2023, 55 (02)
  • [33] Nephrolithiasis and sodium-glucose co-transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials
    Cosentino, Claudia
    Dicembrini, Ilaria
    Nreu, Besmir
    Mannucci, Edoardo
    Monami, Matteo
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 155
  • [34] Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and cancer: A meta-analysis of randomized controlled trials
    Dicembrini, Ilaria
    Nreu, Besmir
    Mannucci, Edoardo
    Monami, Matteo
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (08) : 1871 - 1877
  • [35] Sodium-glucose co-transporter-2 inhibitors and the risk of diabetic ketoacidosis in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials
    Liu, Jiali
    Li, Ling
    Li, Sheyu
    Wang, Yuning
    Qin, Xuan
    Deng, Ke
    Liu, Yanmei
    Zou, Kang
    Sun, Xin
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (09) : 1619 - 1627
  • [36] The effect of sodium-glucose co-transporter-2 (SGLT2) inhibitors on blood interleukin-6 concentration: a systematic review and meta-analysis of randomized controlled trials
    Gohari, Sepehr
    Ismail-Beigi, Faramarz
    Mahjani, Mahsa
    Ghobadi, Saeed
    Jafari, Alireza
    Ahangar, Hassan
    Gohari, Sheida
    [J]. BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [37] The effect of sodium-glucose co-transporter-2 (SGLT2) inhibitors on blood interleukin-6 concentration: a systematic review and meta-analysis of randomized controlled trials
    Sepehr Gohari
    Faramarz Ismail-Beigi
    Mahsa Mahjani
    Saeed Ghobadi
    Alireza Jafari
    Hassan Ahangar
    Sheida Gohari
    [J]. BMC Endocrine Disorders, 23
  • [38] Effect of sodium-glucose co-transporter 2 inhibitors on plasma potassium: A meta-analysis
    Charlwood, Chloe
    Chudasama, Jenika
    Darling, Andrea L.
    Ellis, Hugh Logan
    Whyte, Martin B.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 196
  • [39] The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review and meta-analysis
    Muhammad Usman Ali
    G. B. John Mancini
    Donna Fitzpatrick-Lewis
    Kim A. Connelly
    Eileen O’Meara
    Shelley Zieroth
    Diana Sherifali
    [J]. Cardiovascular Diabetology, 23
  • [40] The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review and meta-analysis
    Ali, Muhammad Usman
    Mancini, G. B. John
    Fitzpatrick-Lewis, Donna
    Connelly, Kim A.
    O'Meara, Eileen
    Zieroth, Shelley
    Sherifali, Diana
    [J]. CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)